Jinxin Fertility Group Limited (HKG:1951)

Market Cap	8.26B
Revenue (ttm)	2.99B
Net Income (ttm)	301.27M
Shares Out	2.74B
EPS (ttm)	0.11
PE Ratio	28.28
Forward PE	15.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,065,500
Average Volume	164,560,827
Open	2.960
Previous Close	2.960
Day's Range	2.910 - 3.060
52-Week Range	2.070 - 4.640
Beta	1.44
RSI	50.89
Earnings Date	Mar 28, 2025

About Jinxin Fertility Group

Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband’s sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, an...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1951
• Employees: 3,192
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1951

Financial Performance

In 2024, Jinxin Fertility Group's revenue was 2.81 billion, an increase of 0.81% compared to the previous year's 2.79 billion. Earnings were 283.10 million, a decrease of -17.88%.

Financial numbers in CNY